Cargando…

Increased Serum Cystatin C in Early Parkinson's Disease with Objective Sleep Disturbances

BACKGROUND: Sleep disturbance is one of the major non-motor symptoms which cause the disability of Parkinson's disease (PD) patients. Cystatin C (CysC) is a more sensitive biomarker than serum creatinine or estimated glomerular filtration rate. Previous studies have reported altered CysC levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Kang-Ping, Dai, Yong-Ping, Chen, Jing, Xu, Jin-Min, Wang, Yi, Feng, Ping, You, Shou-Jiang, Liu, Chun-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912055/ https://www.ncbi.nlm.nih.gov/pubmed/29664049 http://dx.doi.org/10.4103/0366-6999.229902

Ejemplares similares

Management Recommendations on Sleep Disturbance of Patients with Parkinson's Disease
por: Liu, Chun-Feng, et al.
Publicado: (2018)

Fatigue correlates with sleep disturbances in Parkinson disease
por: Cao, Xiang-Yang, et al.
Publicado: (2021)

Increased serum cystatin C levels and responses of pancreatic α- and β-cells in type 2 diabetes
por: Yuan, Hui-qing, et al.
Publicado: (2022)

Sleep Disturbances Associated with Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2011)

Parkinson's Disease and Sleep/Wake Disturbances
por: Swick, Todd J.
Publicado: (2012)

Management of Sleep Disturbances in Parkinson’s Disease
por: Schütz, Lukas, et al.
Publicado: (2022)

Editorial: Sleep disturbances in Parkinson's disease
por: Salsone, Maria, et al.
Publicado: (2023)

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)

Effect of ALDH2 on Sleep Disturbances in Patients with Parkinson’s Disease
por: Lin, Chia-Yen, et al.
Publicado: (2019)

Sleep disturbances in Taiwanese patients with Parkinson's disease
por: Lin, Yi‐Ying, et al.
Publicado: (2017)

Longitudinal Studies of Sleep Disturbances in Parkinson’s Disease
por: Xu, Zheyu, et al.
Publicado: (2022)

A magnetic solid phase chemiluminescent immunoassay for quantification of Cystatin C in human serum
por: He, Jian, et al.
Publicado: (2023)

Self-reported sleep disturbance in Crohn’s disease is not confirmed by objective sleep measures
por: Iskandar, Heba N., et al.
Publicado: (2020)

Early onset of sleep/wake disturbances in a progressive macaque model of Parkinson’s disease
por: Davin, Aurélie, et al.
Publicado: (2022)

Sleep disturbances in Parkinson’s disease patients and management options
por: Claassen, Daniel O, et al.
Publicado: (2011)

Sleep disturbances and depression severity in patients with Parkinson's disease
por: Kay, Daniel B., et al.
Publicado: (2018)

Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease
por: Minakawa, Eiko N.
Publicado: (2022)

Sleep Disturbances in Parkinson's Disease: Is It Related to COVID-19?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2022)

Elevated Serum Liver Enzymes in Patients with Obstructive Sleep Apnea-hypopnea Syndrome
por: Li, Jie, et al.
Publicado: (2015)

Research advances in the study of sleep disorders, circadian rhythm disturbances and Alzheimer’s disease
por: Xiong, Xiangyang, et al.
Publicado: (2022)

Sleep Disturbances and Sleep Disordered Breathing Impair Cognitive Performance in Parkinson’s Disease
por: Hermann, Wiebke, et al.
Publicado: (2020)

Serum Levels of TNF-α Are Increased in Patients with Rotator Cuff Tear and Sleep Disturbance
por: Cho, Chul-Hyun, et al.
Publicado: (2021)

The Importance of Early Identification for Parkinson's Disease Patients with Postural Instability and Gait Disturbance
por: Wu, You, et al.
Publicado: (2022)

Serum Cystatin C Reflects the Progress of Albuminuria
por: Yoo, Jeong Seon, et al.
Publicado: (2011)

The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma
por: Tan, Ping, et al.
Publicado: (2019)

Correlation of Sleep Disturbance and Cognitive Impairment in Patients with Parkinson’s Disease
por: Kim, Eun Ja, et al.
Publicado: (2014)

Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease
por: Bohnen, Nicolaas I., et al.
Publicado: (2019)

Sleep disturbances in Parkinson’s disease are associated with central parkinsonian pain
por: Vila-Chã, N, et al.
Publicado: (2019)

Subtypes of Sleep Disturbance in Parkinson's Disease Based on the Cross-Culturally Validated Korean Version of Parkinson's Disease Sleep Scale-2
por: Yang, Hui-Jun, et al.
Publicado: (2020)

Sleep Spindles Predict Stress-Related Increases in Sleep Disturbances
por: Dang-Vu, Thien Thanh, et al.
Publicado: (2015)

Sleep disturbances in drug naïve Parkinson's disease (PD) patients and effect of levodopa on sleep
por: Ferreira, Teresa, et al.
Publicado: (2014)

Rhythm disturbances as a potential early marker of Parkinson’s disease in idiopathic REM sleep behavior disorder
por: Cochen De Cock, Valérie, et al.
Publicado: (2020)

Higher serum level of Cystatin C: An additional risk factor of CAD
por: Chen, Zhenfei, et al.
Publicado: (2021)

Neuropeptide S Counteracts Paradoxical Sleep Deprivation-Induced Anxiety-Like Behavior and Sleep Disturbances
por: Xie, Jun-Fan, et al.
Publicado: (2018)

Sleep Disturbances in Child and Adolescent Mental Health Disorders: A Review of the Variability of Objective Sleep Markers
por: Baddam, Suman K. R., et al.
Publicado: (2018)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
por: Gashenko, Elena A., et al.
Publicado: (2013)

Brain MRI morphometric analysis in Parkinson’s disease patients with sleep disturbances
por: Radziunas, Andrius, et al.
Publicado: (2018)

Sleep disturbances and gastrointestinal dysfunction are associated with thalamic atrophy in Parkinson’s disease
por: Niccolini, Flavia, et al.
Publicado: (2019)

Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson’s Disease
por: Zhong, Min, et al.
Publicado: (2021)

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
por: Ding, Ping’an, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cvic46c3docmi9rnk3oetpglin